Ebola Virus Net is the web resource for anyone interested in ebola. Ebola (Ebola hemorrhagic fever), is a severe, often fatal disease in humans and nonhuman primates such as monkeys, gorillas, and chimpanzees. Ebola is a rare and deadly disease caused by infection with a virus of the family Filoviridae, genus Ebolavirus. There are five identified Ebolavirus species, four of which have caused disease in humans. Ebola is found in several African countries. The first Ebola species was discovered in 1976 near the Ebola River in the Democratic Republic of the Congo. Since then, outbreaks have appeared sporadically in Africa. The largest outbreak to date was the epidemic in West Africa, which occurred from December 2013, to January 2016, with 28,646 cases and 11,323 deaths. Other outbreaks in Africa began in the Democratic Republic of the Congo in May 2017 and 2018. In July 2019, the World Health Organization declared the Congo Ebola outbreak a world health emergency.

When an infection does occur in humans, the virus can be spread to others through direct contact with the blood or body fluids of a person who is sick with Ebola, or through contact with objects that have been contaminated with the blood or body fluids of an infected person. Until recent, no vaccines were effective. In December 2016, Ebola was found to be 70–100% prevented by rVSV-ZEBOV vaccine, making it the first proven vaccine against the disease. More than 100,000 people have been vaccinated against Ebola as of 2019.

The objectives of Ebola Virus Net are to be the public and professional information resource for ebola and to serve as a network in the exchange of information and news related to ebola.

• Uganda receives 1200 doses of Ebola vaccine candidates for trials - Reuters
  Thu, 08 Dec 2022 10:33 GMT
• As Ebola outbreak grows in Uganda, US ramps up preparedness plans - CNN
  Wed, 16 Nov 2022 08:00 GMT
• Ebola Outbreak In Uganda Is Waning, Ministry Of Health Remains Vigilant - Forbes
  Wed, 30 Nov 2022 08:00 GMT
• Ebola outbreak in Uganda prompts monitoring - UCHealth Today
  Thu, 10 Nov 2022 08:00 GMT
• Ugandan authorities remain vigilant as last Ebola patient discharged - FRANCE 24 English
  Thu, 08 Dec 2022 11:57 GMT
• Sustainable strategies for Ebola virus disease outbreak preparedness in Africa: a case study on lessons learnt in countries neighbouring the Democratic Republic of the Congo - Infectious Diseases of Poverty - Infectious Diseases of Poverty - BioMed Central
  Fri, 02 Dec 2022 11:08 GMT
• Ebola Virus Disease: Ad26.ZEBOV Booster Dose Safe and Immunogenic in Children - Infectious Disease Advisor
  Mon, 05 Dec 2022 16:52 GMT
• UK investigates possible Ebola case - Becker's Hospital Review
  Mon, 21 Nov 2022 08:00 GMT
• The tools Uganda is using to fight Ebola outbreak - Medical Xpress
  Mon, 21 Nov 2022 08:00 GMT
• Congolese Bishop Known for Spearheading Fight against Ebola in DR Congo Dies in Belgium - ACI Africa
  Thu, 08 Dec 2022 07:58 GMT
• DCGI gives nod to SII-manufactured Ebola vaccine for export to Uganda - Devdiscourse
  Thu, 08 Dec 2022 11:39 GMT
• Global clinical data platform Ebola virus disease case report form (CRF) module 3 - World - ReliefWeb
  Wed, 30 Nov 2022 08:00 GMT
• Ebola - BC Centre for Disease Control
  Thu, 10 Nov 2022 23:34 GMT
• Persistent intraocular Ebola virus RNA is associated with severe uveitis in a convalescent rhesus monkey | Communications Biology - Nature.com
  Wed, 09 Nov 2022 08:00 GMT
• Global Ebola Virus Vaccine Market Report Insights, Outlook and Forecast 2023-2030 – PRIZM News - PRIZM News
  Thu, 08 Dec 2022 00:11 GMT

• PRO/AH/EDR> Ebola update (44): Burkina Faso ex Cote d'Ivoire, 2nd case, NOT
  Mon, 30 Aug 2021 11:01:25 -0400
  Ebola -- Burkina Faso
  On 22 Aug 2021, the Ministry of Health informed the population of the admission to the Medical Emergencies of the Bogodogo University Hospital (CHU-B) of a 22-year-old patient who had stayed in the Republic of [Cote d'Ivoire]. The diagnostic procedure consisted of sampling analysis at the National Reference Laboratory for Viral Haemorrhagic Fever (LNR-FHV at the Muraz Centre) and the Pasteur Institute of Dakar for confirmation. The results obtained make it possible to permanently rule out

• Attacks on Health Care Workers in Historical Pandemics and COVID-19 Wed, 07 Dec 2022 06:00:00 -0500
  No abstract
• A Review: The Antiviral Activity of Cyclic Peptides Tue, 06 Dec 2022 06:00:00 -0500
  No abstract
• The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion Mon, 05 Dec 2022 06:00:00 -0500
  No abstract
• Social Network Analysis of Ebola Virus Disease During the 2014 Outbreak in Sukudu, Sierra Leone Mon, 05 Dec 2022 06:00:00 -0500
  No abstract
• Ensuring continuity of care during the COVID-19 pandemic in Guinea: Process evaluation of a health indigent fund Mon, 05 Dec 2022 06:00:00 -0500
  No abstract
• MP-VHPPI: Meta predictor for viral host protein-protein interaction prediction in multiple hosts and viruses Mon, 05 Dec 2022 06:00:00 -0500
  No abstract
• Public health and military health Mon, 05 Dec 2022 06:00:00 -0500
  No abstract
• RBM24 inhibits the translation of SARS-CoV-2 polyproteins by targeting the 5'-untranslated region Sun, 04 Dec 2022 06:00:00 -0500
  No abstract
• Ebola outbreak in Uganda: patient values and preferences Sun, 04 Dec 2022 06:00:00 -0500
  No abstract
• Community engagement in Ebola outbreaks in sub-Saharan Africa and implications for COVID-19 control: A scoping review Sat, 03 Dec 2022 06:00:00 -0500
  No abstract